000			01728 a2200493 4500
005			20250513033834.0
264		0	_c19950817
008			199508s 0 0 eng d
022			_a0008-5472
040			_aNLM _beng _cNLM
100	1		_aDhingra, K
245	0	0	_aPhase I clinical and pharmacological study of suppression of human antimouse antibody response to monoclonal antibody L6 by deoxyspergualin. _h[electronic resource]
260			_bCancer research _cJul 1995
300			_a3060-7 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase I; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntibiotics, Antineoplastic _xadverse effects
650	0	4	_aAntibodies, Anti-Idiotypic _xbiosynthesis
650	0	4	_aAntibodies, Monoclonal _xadverse effects
650	0	4	_aAntibody Formation _xdrug effects
650	0	4	_aComplement Activation _xdrug effects
650	0	4	_aComplement C3 _xmetabolism
650	0	4	_aComplement C4 _xmetabolism
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Interactions
650	0	4	_aFemale
650	0	4	_aGuanidines _xadverse effects
650	0	4	_aHumans
650	0	4	_aIsoantigens _ximmunology
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasms _xdrug therapy
700	1		_aFritsche, H
700	1		_aMurray, J L
700	1		_aLoBuglio, A F
700	1		_aKhazaeli, M B
700	1		_aKelley, S
700	1		_aTepper, M A
700	1		_aGrasela, D
700	1		_aBuzdar, A
700	1		_aValero, V
773	0		_tCancer research _gvol. 55 _gno. 14 _gp. 3060-7
999			_c7606166 _d7606166